Brief: AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
28/10/2025 12:11
Oct 28 (Reuters) - AtriCure Inc ATRC.O: ATRICURE ANNOUNCES THE FIRST PATIENT TREATED IN THE BOXX-NOAF CLINICAL TRIAL Source text: ID:nBw1Rk6bwa Further company coverage: ATRC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AtriCure
See all newsAtriCure Q1 revenue beats estimates, co raises 2026 outlook
Brief: AtriCure Q1 Revenue USD 141.2 Million Vs. IBES Estimate USD 139.8 Million
AtriCure beats Q4 profit estimates
Brief: AtriCure Q4 Adjusted EPS USD 0.06 Vs. IBES Estimate USD -0.1
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates